Global Prosthetic Heart Valve Market According to Data Bridge Market Research new Market report, “By Product Type (Trans catheter Heart Valve, Tissue Heart Valve, Mechanical Heart Valve), By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends and Forecast is projected to reach USD 14.04 billion by 2025, at a CAGR of 13.4% during the forecast period of 2018 to 2025.

Request For Sample @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-prosthetic-heart-valve-market

Global Prosthetic Heart Valve Market

Prosthetic heart valve which is also called as artificial heart valve is implanted in the heart of a patient with valvular heart disease. At c certain stage when treatment of heart valve disease does not provide relief to the patient, then this surgery is recommended as the best way to repair the valve. 

The life of a tissue valve is 10 to 15 years. Advancements in technology and increasing prevalence of heart valve diseases. In the U.S., only about 2,000 hearts are available each year, while there are 3,000 people waiting for a new heart. 

Inquiry Before Buying @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-prosthetic-heart-valve-market

Segmentation:

The global market for prosthetic heart value by the following sub-categories is presented

By Product Type

Transcatheter Heart Valve
Tissue Heart Valve
Mechanical Heart Valve
By Geography

North America
South America
Europe
Asia-Pacific
Middle East and Africa
Request For TOC @ https://databridgemarketresearch.com/toc/?dbmr=global-prosthetic-heart-valve-market

FACTORS DRIVING GROWTH IN THE GLOBAL PROSTHETIC HEART VALVE MARKET

Increase in the prevalence of heart value disease and valvular heart disease:

The leading of death in U.S. is heart disease, killing more than 600,000 Americans each year. It was found that each year more than 5 million Americans are diagnosed with heart value disease.  Heart valve disease can occur in any single valve or a combination of the four valves, but diseases of the aortic and mitral valves are the most common. 

Rise in prevalence of cardiac disorders:

According to center for disease control and prevention, coronary heart disease is the most common type of heart disease, killing about 366,000 people in 2015. In the United States, there is a case of heart attack in every 40 seconds.

Every minute, more than one person in the United States dies from a heart disease-related event. It was found that heart disease costs the United States around USD 200 billion each year.

Speak to Analyst @ https://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-prosthetic-heart-valve-market

Major Players:

Some of the major market players in this market are

Medtronic, Edwards Lifesciences Corporation,
Boston Scientific Corporation,
Abbott,
LivaNova PLC,
Boston Scientific Corporation,
JenaValve Technology Inc,
CryoLife, Inc,
TTK HealthCare,
Colibri Heart Valve,
lepumedica,
Braile Biomédica,
Comed B.V.,
HLT,
XELTIS,
Meril Life Sciences Pvt. Ltd,
Scranton Gillette Communications
Please Read More Impact Content in Detail @ https://databridgemarketresearch.com/news/product-launch/global-prosthetic-heart-valve-market/

About Us-

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact Us-

Data Bridge Market Research

US: +1-888-387-2818

Email: [email protected]

Website: https://databridgemarketresearch.com